Angiotensin-converting enzyme and metals in untreated essential hypertension

被引:0
|
作者
Ozlem Balci Ekmekci
Orkide Donma
Aydin Tunckale
机构
[1] Istanbul University,Department of Biochemistry
[2] Istanbul University,Department of Internal Medicine, Cerrahpasa Medical Faculty
来源
关键词
Essential hypertension; ACE; Zn; divalent; monovalent; cations;
D O I
暂无
中图分类号
学科分类号
摘要
Hpertension is an important health problem throughout the world and a risk factor for many diseases. Angiotensin-converting enzyme (ACE), a component of the renin-angiotensin system, has an important role in the regulation of blood pressure. Zinc (Zn), a trace element with important biological functions, is located in the catalytic site of ACE. Calcium (Ca), magnesium (Mg), sodium (Na), and potassium (K) also appear to be involved in hypertension pathogenesis. In this study, plasma ACE activities and Cat, Cai, Mg, Na, K, and plasma/erythrocyte Zn levels of 20 untreated patients with essential hypertension and 28 helthy individuals were evaluated. Plasma ACE activities (p<0.05) and erythrocyte Zn concentrations (p<0.001) were significantly higher in patients with essential hypertension than values of the control group. No significant difference was found between plasma Zn concentrations of the groups (p>0.05). Plasma Cat (p<0.001) and Mg levels (p<0.05) in essential hypertension were significantly lower than those of controls. Plasma Na, K, and Cai levels remained normal in essential hypertension. There are complex associations between metals and arterial pressure. Ca and Mg deficiencies seem to be associated with increased prevalence of hypertension. Increases in erythrocyte Zn may have a future potential use for diagnosis of hypertension.
引用
收藏
页码:203 / 210
页数:7
相关论文
共 50 条
  • [31] ANGIOTENSIN-CONVERTING ENZYME IN PREGNANCY-INDUCED HYPERTENSION
    OATS, JN
    LONG, PA
    ANDERSEN, HM
    BEATON, LA
    CLINICAL AND EXPERIMENTAL HYPERTENSION PART B-HYPERTENSION IN PREGNANCY, 1982, 1 (2-3): : 231 - 231
  • [32] ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS IN THE TREATMENT OF HYPERTENSION
    JOHNSTON, CI
    ARNOLDA, L
    HIWATARI, M
    DRUGS, 1984, 27 (03) : 271 - 277
  • [33] Angiotensin-converting enzyme gene polymorphism in systemic hypertension
    Abbud, ZA
    Wilson, AC
    Cosgrove, NM
    Kostis, JB
    AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (02): : 244 - 246
  • [34] THERAPY OF HYPERTENSION WITH ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS
    SCHAFER, GE
    INNERE MEDIZIN, 1986, 13 (05) : 207 - 212
  • [35] MONOTHERAPY OF HYPERTENSION WITH ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS
    MATERSON, BJ
    AMERICAN JOURNAL OF MEDICINE, 1984, 77 (4A): : 128 - 134
  • [36] ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS IN THE TREATMENT OF HYPERTENSION
    MANCIA, G
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 18 : S1 - S3
  • [37] Angiotensin-Converting Enzyme Inhibitors in Hypertension To Use or Not to Use?
    Messerli, Franz H.
    Bangalore, Sripal
    Bavishi, Chirag
    Rimoldi, Stefano F.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (13) : 1474 - 1482
  • [38] Recent megatrials on angiotensin-converting enzyme inhibitors in hypertension
    Alcocer, L
    CARDIOVASCULAR PHARMACOTHERAPY, 2000, : 153 - 158
  • [39] ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS IN HYPERTENSION - A REVIEW
    SALVETTI, A
    PEDRINELLI, R
    ARZILLI, F
    ABDELHAQ, B
    MAGAGNA, A
    LUCARINI, A
    GRAZIADEI, L
    NUCCORINI, A
    TADDEI, S
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 1985, 5 (06) : 429 - 438
  • [40] IMPORTANCE OF ANGIOTENSIN-CONVERTING ENZYME IN PULMONARY-HYPERTENSION
    ABRAHAM, WT
    RAYNOLDS, MV
    GOTTSCHALL, B
    BADESCH, DB
    WYNNE, KM
    GROVES, BM
    LOWES, BD
    BRISTOW, MR
    PERRYMAN, MB
    VOELKEL, NF
    CARDIOLOGY, 1995, 86 : 9 - 15